Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy

Azar, Dimitri T.; Ang, Robert T.; Lee, Jae Bum; Kato, Takuji; Chen, Chun Chen; Jain, Sandeep; Gabison, Éric; Abad, Juan Carlos

doi:10.1097/00055735-200108000-00014

Cited by 156 publications

(92 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…[3][4][5][6] Laser in situ keratomileusis and PRK also may be unsuitable refractive choices for certain patients who have corneal thinning or for patients who have higher potential risk for corneal injuries. 7 In these groups of patients, LASEK has been proposed to be a superior alternative refractive procedure.…”

Section: Discussionmentioning

confidence: 99%

A Randomized Prospective Clinical Trial Comparing Laser SubepithelialKeratomileusis and Photorefractive Keratectomy

Pirouzian¹

2004

Arch Ophthalmol

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

A Randomized Prospective Clinical Trial Comparing Laser SubepithelialKeratomileusis and Photorefractive Keratectomy

Pirouzian¹

2004

Arch Ophthalmol

View full text Add to dashboard Cite

show abstract

“…The technique was introduced in 2001. 35 Since then, it has been realised in randomised studies that the technique is not superior to conventional PRK in terms of patient comfort, reduction of haze or regression. 28 It seems that the manipulation of the epithelium would leave non-surviving cell and that the biological barrier of the replaced epithelial cells is insufficient to reduce a wound-healing response.…”

Section: Laser Subepithelial Keratomileusismentioning

confidence: 99%

Surface Ablation Techniques for Myopia – A Review of the Advances Over the Past 25 Years

Hjortdal¹

2017

European Ophthalmic Review

View full text Add to dashboard Cite

Photorefractive keratectomy for correction of myopia was the first excimer laser-based technique to be developed. During the last 25 years, excimer lasers have improved technologically, several variations of the technique have been developed and pre-and postoperative pharmaceutical therapies have been investigated. This review article summarises these developments and the published meta-analyses on comparison of surface ablation techniques and laser in situ keratomileusis. The main conclusion is that there seem to be no differences between the clinical results obtained with the different variations of surface ablation techniques. KeywordsPhotorefractive keratectomy, laser in situ keratomileusis (LASIK), refractive surgical procedures, myopia, excimer laser Disclosure: Jesper Hjortdal discloses that Aarhus University Hospital has signed a research support agreement with Carl Zeiss Meditec, Jena Germany. No funding was received in the publication of this article. This study involves a review of the literature and did not involve any studies with human or animal subjects performed by any of the authors.Authorship: All named authors meet the International Committee of Medical Journal Editors (ICMJE) criteria for authorship of this manuscript, take responsibility for the integrity of the work as a whole, and have given final approval to the version to be published.Open Access: This article is published under the Creative Commons Attribution Noncommercial License, which permits any non-commercial use, distribution, adaptation and reproduction provided the original author(s) and source are given appropriate credit. When such a gas is put under electrical stimulation and high pressure, the excited compound can give up its excess energy by undergoing spontaneous emission, which very quickly (on the order of a picosecond) dissociates back into two unbound atoms. Directing the emitted light towards, for example, biological materials will result in ablation of surface molecules. In the early 1980s it was shown that using this approach biological materials, including the cornea, could be incised using the excimer laser.1-3 After short time, it was realised that actual surface ablation of the corneal stroma was possible after removal of the corneal epithelium 4 and that the resulting surface was very smooth. 5 In 1987, excimer laser-based keratotomy was performed in a human eye, 6 but it was the surface ablation application that pushed development of excimer lasers. 7,8 The first preliminary results in human eyes were published the late 1980s 9-12 and excimer lasers became commercially available around 1990. In the early 1990s larger follow-up series of patients undergoing PRK for myopia were published. [13][14][15] Since then, many modifications of PRK have been introduced, and a common uniting name for all these techniques is 'surface ablation'. This review will focus on surface ablation for myopia. Development of excimer lasersDirecting the location of the excimer laser rays is essential to change the surface shape of the ...

show abstract

“…It has no flap-related complications, reduces the risk of keratectasia associated with LASIK and had been shown to be a safe, effective and predictable treatment for low [1], mild [2] and high [3]- [6] myopia from its introduction [7] [8]. Nevertheless, a clinically significant haze has occurred in >30% [7] [9] of eyes at 3 months, 6.9% [4] of at 6 months and 3.8% [10] of eyes at 1 year.…”

Section: Introductionmentioning

confidence: 99%

Re-Evaluation of the Safety of Laser-Assisted Subepithelial Keratectomy

Kumano¹,

Soejima²,

Numa³

et al. 2014

OJOph

View full text Add to dashboard Cite

Purpose: Additional analyses of outcomes of laser-assisted subepithelial keratectomy (LASEK) are still necessary to improve the safety of LASEK. Therefore, in our study, outcomes were assessed retrospectively in 561 eyes that underwent LASEK treatment. Methods: Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA) and residual spherical equivalent were analyzed at 3 and 6 months postoperatively. We assessed four subgroups based on the degree of preoperative myopia considering mean BSCVA and loss of two or more lines. Results: Mean UCVAs and BSCVAs were obtained at 3 and 6 months postoperatively (1.23/1.35 and 1.23/1.37, respectively). The mean predictability was within ±0.125 diopters. Conversely, the safety indexes were 0.94 and 0.96 respectively, and the efficacy indexes were 0.86 and 0.86 at 3 and 6 months postoperatively, respectively. 8.4% eyes and 5.2% eyes lost two or more lines of BSCVA at 3 and 6 months postoperatively, respectively. The mean BSCVAs of the high or ultra-high groups were significantly lower than those of the low or mild groups both 3 months and 6 months postoperatively. The incidence rates of losing two or more lines of BSCVA in the high or ultra-high myopia groups were significantly greater than in the low or mild groups at 3 months and 6 months postoperatively. Conclusion: LASEK predictably corrected myopia achieving >1.2 in UCVA and BSCVA. However, the safety and efficacy indexes were <1.0, which were related to the loss of two or more lines of BSCVA. Since the incidence rates of losing two or more lines of BSCVA were greater in the high or ultra-high myopia groups, we consider LASEK as more safely performed in patients with low to mild preoperative myopia.

show abstract

Laser subepithelial keratomileusis: electron microscopy and visual outcomes of flap photorefractive keratectomy

Cited by 156 publications

References 8 publications

A Randomized Prospective Clinical Trial Comparing Laser SubepithelialKeratomileusis and Photorefractive Keratectomy

A Randomized Prospective Clinical Trial Comparing Laser SubepithelialKeratomileusis and Photorefractive Keratectomy

Surface Ablation Techniques for Myopia – A Review of the Advances Over the Past 25 Years

Re-Evaluation of the Safety of Laser-Assisted Subepithelial Keratectomy

Contact Info

Product

Resources

About